IL37 and hematologic disorder: Recent studies also showed the direct antitumor activities of IL-23/IL-23R in human hematologic malignancies, i.e., pediatric acute leukemia, and IL-23 directly dampens tumor growth in vitro and in vivo through the inhibition of tumor cell proliferation and induction of apoptosis [9], [10].